GENERATIVE BIOLOGICS

Serial Number 98387645
774

Registration Progress

Application Filed
Feb 1, 2024
Under Examination
Approved for Publication
Dec 3, 2024
Published for Opposition
Dec 3, 2024
Registered

Trademark Image

GENERATIVE BIOLOGICS

Basic Information

Serial Number
98387645
Filing Date
February 1, 2024
Published for Opposition
December 3, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
774
Status Date
Apr 2, 2025
Application
Pending
Classes
009 042

Rights Holder

Insilico Medicine IP Limited

99
Address
26th Floor
Three Exchange Square, 8 Connaught Place
Central, Hong Kong 999077
CN

Ownership History

Insilico Medicine IP Limited

Original Applicant
99
Central, Hong Kong CN

Insilico Medicine IP Limited

Owner at Publication
99
Central, Hong Kong CN

Legal Representation

Attorney
JACQUELINE M. LESSER

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description Documents
Apr 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Apr 2, 2025 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Dec 17, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 27, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 16, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 16, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 28, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 28, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 28, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 28, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 5, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 009
Downloadable and recorded computer software; recorded or downloadable computer software platforms using artificial intelligence for automated machine learning in the field of biologics design and development; computer operating programs, recorded; data processing apparatus
Class 042
Technological research relating to patent mapping; scientific research and development; scientific and technical research relating to patent mapping; research in the field of artificial intelligence; research and development of new products; scientific laboratory services, namely laboratory services in biologics design and development; cancer research for medical purposes; artificial intelligence consultancy in biologics design and development, namely, chemistry services, clinical trials, biomedical research services, medical laboratory service, medical research service; design and development of computer software; design and development of computer software, namely developing customized software in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; computer software installation, maintenance and repair and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; development of computer platforms; research in computer natural language processing; design of computer-simulated models; software as a service (SAAS) services featuring software for using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; software development in the framework of software publishing; platform as a service (PAAS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of biologics design and development, including peptides, nanobodies, and antibodies tailored for specific targets; development of computer platforms; computer system design; rental of computer software; creating and designing website based indexes of data and information for others using information technology; computer programming services; maintenance of computer software; installation of computer software; installation, maintenance, and updating of computer software

Classification

International Classes
009 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIOLOGICS